Biotech Values

[jq1234]

you're assuming PPHM is intentionally misleading the public and accusing them of being fraudulent.

PPHM gave out primary endpoint ORR and secondary endpoint PFS numbers without stating whether they are statistically significant or not. Obviously there are people who are dumb enough to believe they are or don't know the difference. PPHM then artifully shifted the discussion from ORR/PFS to MOS. Whether this is intentionally or not is in the eyes of beholders.

is it because the results are too good to be true if they're not lying/misrepresenting?

What is it too good to be true? Missing primary and secondary trial endpoints?

if they get a partnership deal in the fairly near term after what will surely be exhaustive due diligence on the research details, what will be your basis for assuming there isn't any validity then?

Come back after they ACTUALLY get a big pharma partnership.